Yousif Capital Management LLC Has $2.18 Million Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Yousif Capital Management LLC lowered its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 1.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,514 shares of the medical instruments supplier’s stock after selling 401 shares during the quarter. Yousif Capital Management LLC’s holdings in Merit Medical Systems were worth $2,178,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Farther Finance Advisors LLC grew its holdings in shares of Merit Medical Systems by 32.7% during the third quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 260 shares during the last quarter. Harvest Fund Management Co. Ltd bought a new position in Merit Medical Systems in the 3rd quarter valued at about $120,000. GAMMA Investing LLC boosted its stake in Merit Medical Systems by 56.8% during the 3rd quarter. GAMMA Investing LLC now owns 1,303 shares of the medical instruments supplier’s stock valued at $129,000 after purchasing an additional 472 shares during the last quarter. TD Private Client Wealth LLC increased its holdings in Merit Medical Systems by 13.9% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier’s stock worth $171,000 after purchasing an additional 211 shares in the last quarter. Finally, Ballentine Partners LLC purchased a new stake in shares of Merit Medical Systems in the fourth quarter worth approximately $200,000. Institutional investors own 99.66% of the company’s stock.

Insiders Place Their Bets

In other news, Director F. Ann Millner sold 12,500 shares of Merit Medical Systems stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $101.55, for a total value of $1,269,375.00. Following the completion of the transaction, the director now owns 32,391 shares in the company, valued at $3,289,306.05. This trade represents a 27.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on MMSI shares. Raymond James lifted their target price on Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Tuesday, December 31st. Piper Sandler reaffirmed an “overweight” rating and set a $116.00 price objective (up from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Needham & Company LLC increased their target price on shares of Merit Medical Systems from $109.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Wells Fargo & Company upgraded shares of Merit Medical Systems from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $103.00 to $120.00 in a report on Wednesday, December 11th. Finally, Robert W. Baird increased their price objective on shares of Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Merit Medical Systems currently has an average rating of “Moderate Buy” and an average price target of $109.80.

Merit Medical Systems Trading Up 0.7 %

Shares of MMSI stock opened at $109.92 on Tuesday. Merit Medical Systems, Inc. has a 12-month low of $70.70 and a 12-month high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. The company has a 50 day moving average of $101.99 and a 200-day moving average of $98.23. The firm has a market cap of $6.41 billion, a P/E ratio of 53.88, a PEG ratio of 2.42 and a beta of 0.87.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.